InvisibleDx

Post-Acute Infection Syndrome

Evidence-based diagnostic framework for post-infection conditions

Clinical Framework

Immune Dysregulation as Pathophysiological Basis

Post-Acute Infection Syndrome (PAIS), including ME/CFS and Long COVID, represents a spectrum of chronic conditions following acute infection. Characterized by persistent immune dysregulation, T-cell exhaustion, and autonomic dysfunction, documented by peer-reviewed research and recognized by major medical organizations worldwide.

3D rendering of an exhausted T-cell showing surface markers including PD-1 and Tim-3

Figure: 3D visualization of T-cell exhaustion with surface marker expression.

Authoritative Diagnostic Criteria

ME/CFS

Myalgic Encephalomyelitis

Recognized by the Institute of Medicine (IOM, 2015) as a serious, chronic, complex, and systemic disease. Canadian Consensus Criteria (2003) and NICE Guidelines NG206 (2021) provide diagnostic frameworks.

Long COVID

Post-COVID-19 Condition

Recognized by the WHO (2021) as a distinct post-infection condition. CDC and NICE provide clinical case definitions and management guidelines.

Immunology

Objective Biomarkers

Research demonstrates measurable immune dysregulation including T-cell exhaustion, reduced HRV, and complement activation, objective markers documented in peer-reviewed studies.

Diagnostic Tools

Interactive assessments demonstrating how clinical criteria work. Each tool shows which diagnostic criteria it addresses.

Screening
Initial Assessment

PAIS Quick Screen

Initial clinical screening for suspected PAIS based on core symptoms validated by Canadian Consensus Criteria and IOM Report. Maps to diagnostic criteria for ME/CFS and Long COVID.

Open Tool
Comprehensive
Full Criteria Mapping

Diagnostic Criteria Engine

Interactive diagnostic criteria mapping based on Canadian Consensus Criteria (2003), IOM Report (2015), NICE Guidelines NG206 (2021), and WHO Long COVID Definition (2021).

Open Tool
Safety
Differential Diagnosis

Red Flag Assessment

Systematic evaluation for conditions requiring exclusion before PAIS diagnosis. Essential for patient safety and appropriate differential diagnosis per clinical guidelines.

Open Tool
*

This clinical framework is designed for healthcare professionals and is based on peer-reviewed research and diagnostic criteria from major medical organizations. It is not a substitute for clinical judgment. Always consult current medical guidelines and consider individual patient factors in diagnosis and management.